Regulation of NAD(P)H oxidases by AMPK in cardiovascular systems

Free Radical Biology and Medicine

Volumn 52, Issue 9, 2012, Pages 1607-1619

  Song, Ping ^a   Zou, Ming Hui ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

AMPK; Blood cells; Cardiovascular diseases; Endothelial cells; Free radicals; NAD(P)H oxidase; Vascular smooth muscle cells

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADENOSINE MONOPHOSPHATE ACTIVATED PROTEIN KINASE ALPHA1; ADENOSINE MONOPHOSPHATE ACTIVATED PROTEIN KINASE ALPHA2; ADENOSINE MONOPHOSPHATE ACTIVATED PROTEIN KINASE GAMMA1; ADENOSINE MONOPHOSPHATE ACTIVATED PROTEIN KINASE GAMMA2; ADENYLATE KINASE; BETA LAPACHONE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE BETA; CYCLIC AMP DEPENDENT PROTEIN KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; METFORMIN; PROTEIN KINASE B; PROTEIN P22PHOX; PROTEIN P40PHOX; PROTEIN P47PHOX; PROTEIN P53; PROTEIN P67PHOX; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 5; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR SYSTEM; CELL MEMBRANE; CELL MIGRATION; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; CYTOPLASM; DIABETES MELLITUS; DISEASE ASSOCIATION; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FIBROBLAST; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MACROPHAGE; NEOINTIMA; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PULMONARY HYPERTENSION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ADENYLATE KINASE; ANIMALS; CARDIOVASCULAR SYSTEM; ENZYME ACTIVATION; HUMANS; NADPH OXIDASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84858983392     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.01.025     Document Type: Review

References (251)

1. K. Sugamura, and J.F. Keaney Jr. Reactive oxygen species in cardiovascular disease Free Radic. Biol. Med. 51 2011 978 992
2. W. Droge Free radicals in the physiological control of cell function Physiol. Rev. 82 2002 47 95
3. T. Finkel Oxidant signals and oxidative stress Curr. Opin. Cell Biol. 15 2003 247 254
4. M.H. Zou, C. Shi, and R.A. Cohen Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite J. Clin. Invest. 109 2002 817 826
5. J. Wosniak Jr., C.X. Santos, A.J. Kowaltowski, and F.R. Laurindo Cross-talk between mitochondria and NADPH oxidase: effects of mild mitochondrial dysfunction on angiotensin II-mediated increase in Nox isoform expression and activity in vascular smooth muscle cells Antioxid. Redox Signal. 11 2009 1265 1278
6. B. Lassegue, and K.K. Griendling NADPH oxidases: functions and pathologies in the vasculature Arterioscler. Thromb. Vasc. Biol. 30 2010 653 661
7. R.P. Brandes, N. Weissmann, and K. Schroder NADPH oxidases in cardiovascular disease Free Radic. Biol. Med. 49 2010 687 706
8. S. Pendyala, P.V. Usatyuk, I.A. Gorshkova, J.G. Garcia, and V. Natarajan Regulation of NADPH oxidase in vascular endothelium: the role of phospholipases, protein kinases, and cytoskeletal proteins Antioxid. Redox Signal. 11 2009 841 860
9. R.M. Touyz, A.M. Briones, M. Sedeek, D. Burger, and A.C. Montezano NOX isoforms and reactive oxygen species in vascular health Mol. Interv. 11 2011 27 35
10. B. Lassegue, and R.E. Clempus Vascular NAD(P)H oxidases: specific features, expression, and regulation Am. J. Physiol. Regul. Integr. Comp. Physiol. 285 2003 R277 297
11. G.R. Drummond, S. Selemidis, K.K. Griendling, and C.G. Sobey Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets Nat. Rev. Drug Discov. 10 2011 453 471
12. G. Alba, R. El Bekay, M. Alvarez-Maqueda, P. Chacon, A. Vega, J. Monteseirin, C. Santa Maria, E. Pintado, F.J. Bedoya, R. Bartrons, and F. Sobrino Stimulators of AMP-activated protein kinase inhibit the respiratory burst in human neutrophils FEBS Lett. 573 2004 219 225
13. A. Piwkowska, D. Rogacka, M. Jankowski, M.H. Dominiczak, J.K. Stepinski, and S. Angielski Metformin induces suppression of NAD(P)H oxidase activity in podocytes Biochem. Biophys. Res. Commun. 393 2010 268 273
14. A. Salminen, J.M. Hyttinen, and K. Kaarniranta AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan J. Mol. Med. (Berlin) 89 2011 667 676
15. S. Wang, M. Zhang, B. Liang, J. Xu, Z. Xie, C. Liu, B. Viollet, D. Yan, and M.H. Zou AMPKα2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes Circ. Res. 106 2010 1117 1128
16. S.J. Chanock, J. el Benna, R.M. Smith, and B.M. Babior The respiratory burst oxidase J. Biol. Chem. 269 1994 24519 24522
17. J.D. Lambeth NOX enzymes and the biology of reactive oxygen Nat. Rev. Immunol. 4 2004 181 189
18. A.N. Lyle, and K.K. Griendling Modulation of vascular smooth muscle signaling by reactive oxygen species Physiology (Bethesda) 21 2006 269 280
19. M. Geiszt NADPH oxidases: new kids on the block Cardiovasc. Res. 71 2006 289 299
20. S.M. Craige, K. Chen, Y. Pei, C. Li, X. Huang, C. Chen, R. Shibata, K. Sato, K. Walsh, and J.F. Keaney Jr. NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation Circulation 124 2011 731 740
21. A. Sirker, M. Zhang, and A.M. Shah NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies Basic Res. Cardiol. 106 2011 735 747
22. S. Johar, A.C. Cave, A. Narayanapanicker, D.J. Grieve, and A.M. Shah Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase FASEB J. 20 2006 1546 1548
23. R.M. Bell, A.C. Cave, S. Johar, D.J. Hearse, A.M. Shah, and M.J. Shattock Pivotal role of NOX-2-containing NADPH oxidase in early ischemic preconditioning FASEB J. 19 2005 2037 2039
24. Y.H. Looi, D.J. Grieve, A. Siva, S.J. Walker, N. Anilkumar, A.C. Cave, M. Marber, M.J. Monaghan, and A.M. Shah Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction Hypertension 51 2008 319 325
25. J.K. Bendall, A.C. Cave, C. Heymes, N. Gall, and A.M. Shah Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice Circulation 105 2002 293 296
26. J.A. Byrne, D.J. Grieve, J.K. Bendall, J.M. Li, C. Gove, J.D. Lambeth, A.C. Cave, and A.M. Shah Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy Circ. Res. 93 2003 802 805
27. C.P. Judkins, H. Diep, B.R. Broughton, A.E. Mast, E.U. Hooker, A.A. Miller, S. Selemidis, G.J. Dusting, C.G. Sobey, and G.R. Drummond Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice Am. J. Physiol. Heart Circ. Physiol. 298 2010 H24 32
28. P.A. Barry-Lane, C. Patterson, M. van der Merwe, Z. Hu, S.M. Holland, E.T. Yeh, and M.S. Runge p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice J. Clin. Invest. 108 2001 1513 1522
29. A.E. Vendrov, Z.S. Hakim, N.R. Madamanchi, M. Rojas, C. Madamanchi, and M.S. Runge Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells Arterioscler. Thromb. Vasc. Biol. 27 2007 2714 2721
30. M. Thomas, D. Gavrila, M.L. McCormick, F.J. Miller Jr., A. Daugherty, L.A. Cassis, K.C. Dellsperger, and N.L. Weintraub Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice Circulation 114 2006 404 413
31. Z. Chen, J.F. Keaney Jr., E. Schulz, B. Levison, L. Shan, M. Sakuma, X. Zhang, C. Shi, S.L. Hazen, and D.I. Simon Decreased neointimal formation in Nox2-deficient mice reveals a direct role for NADPH oxidase in the response to arterial injury Proc. Natl. Acad. Sci. U. S. A. 101 2004 13014 13019
32. M. Zhang, A.C. Brewer, K. Schroder, C.X. Santos, D.J. Grieve, M. Wang, N. Anilkumar, B. Yu, X. Dong, S.J. Walker, R.P. Brandes, and A.M. Shah NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis Proc. Natl. Acad. Sci. U. S. A. 107 2010 18121 18126
33. H. Peshavariya, G.J. Dusting, F. Jiang, L.R. Halmos, C.G. Sobey, G.R. Drummond, and S. Selemidis NADPH oxidase isoform selective regulation of endothelial cell proliferation and survival Naunyn Schmiedebergs Arch. Pharmacol. 380 2009 193 204
34. S. Basuroy, D. Tcheranova, S. Bhattacharya, C.W. Leffler, and H. Parfenova Nox4 NADPH oxidase-derived reactive oxygen species, via endogenous carbon monoxide, promote survival of brain endothelial cells during TNF-α-induced apoptosis Am. J. Physiol. Cell Physiol. 300 2011 C256 265
35. S. Garrido-Urbani, S. Jemelin, C. Deffert, S. Carnesecchi, O. Basset, C. Szyndralewiez, F. Heitz, P. Page, X. Montet, L. Michalik, J. Arbiser, C. Ruegg, K.H. Krause, and B.A. Imhof Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARα mediated mechanism PLoS One 6 2011 e14665
36. B. Lassegue, D. Sorescu, K. Szocs, Q. Yin, M. Akers, Y. Zhang, S.L. Grant, J.D. Lambeth, and K.K. Griendling Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways Circ. Res. 88 2001 888 894
37. S. Muzaffar, N. Shukla, M. Bond, A.C. Newby, G.D. Angelini, A. Sparatore, P. Del Soldato, and J.Y. Jeremy Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells J. Vasc. Res. 45 2008 521 528
38. R.M. Touyz, X. Chen, F. Tabet, G. Yao, G. He, M.T. Quinn, P.J. Pagano, and E.L. Schiffrin Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II Circ. Res. 90 2002 1205 1213
39. K. Wingler, S. Wunsch, R. Kreutz, L. Rothermund, M. Paul, and H.H. Schmidt Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo Free Radic. Biol. Med. 31 2001 1456 1464
40. S. Wind, K. Beuerlein, M.E. Armitage, A. Taye, A.H. Kumar, D. Janowitz, C. Neff, A.M. Shah, K. Wingler, and H.H. Schmidt Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1/2 is reversed by NADPH oxidase inhibition Hypertension 56 2010 490 497
41. A. Petry, T. Djordjevic, M. Weitnauer, T. Kietzmann, J. Hess, and A. Gorlach NOX2 and NOX4 mediate proliferative response in endothelial cells Antioxid. Redox Signal. 8 2006 1473 1484
42. S. Schuhmacher, M. Foretz, M. Knorr, T. Jansen, M. Hortmann, P. Wenzel, M. Oelze, A.L. Kleschyov, A. Daiber, J.F. Keaney Jr., G. Wegener, K. Lackner, T. Munzel, B. Viollet, and E. Schulz α1AMP-activated protein kinase preserves endothelial function during chronic angiotensin II treatment by limiting Nox2 upregulation Arterioscler. Thromb. Vasc. Biol. 31 2011 560 566
43. M. Ushio-Fukai Compartmentalization of redox signaling through NADPH oxidase-derived ROS Antioxid. Redox Signal. 11 2009 1289 1299
44. C. Dupuy, R. Ohayon, A. Valent, M.S. Noel-Hudson, D. Deme, and A. Virion Purification of a novel flavoprotein involved in the thyroid NADPH oxidase: cloning of the porcine and human cDNAs J. Biol. Chem. 274 1999 37265 37269
45. T. Ago, T. Kitazono, H. Ooboshi, T. Iyama, Y.H. Han, J. Takada, M. Wakisaka, S. Ibayashi, H. Utsumi, and M. Iida Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase Circulation 109 2004 227 233
46. B. Xiao, M.J. Sanders, E. Underwood, R. Heath, F.V. Mayer, D. Carmena, C. Jing, P.A. Walker, J.F. Eccleston, L.F. Haire, P. Saiu, S.A. Howell, R. Aasland, S.R. Martin, D. Carling, and S.J. Gamblin Structure of mammalian AMPK and its regulation by ADP Nature 472 2011 230 233
47. A.C. Montezano, D. Burger, G.S. Ceravolo, H. Yusuf, M. Montero, and R.M. Touyz Novel Nox homologues in the vasculature: focusing on Nox4 and Nox5 Clin. Sci. (Lond.) 120 2011 131 141
48. K. Schroder Isoform specific functions of Nox protein-derived reactive oxygen species in the vasculature Curr. Opin. Pharmacol. 10 2010 122 126
49. A.C. Montezano, D. Burger, T.M. Paravicini, A.Z. Chignalia, H. Yusuf, M. Almasri, Y. He, G.E. Callera, G. He, K.H. Krause, D. Lambeth, M.T. Quinn, and R.M. Touyz Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells Circ. Res. 106 2010 1363 1373
50. D.B. Jay, C.A. Papaharalambus, B. Seidel-Rogol, A.E. Dikalova, B. Lassegue, and K.K. Griendling Nox5 mediates PDGF-induced proliferation in human aortic smooth muscle cells Free Radic. Biol. Med. 45 2008 329 335
51. F.E. Rey, X.C. Li, O.A. Carretero, J.L. Garvin, and P.J. Pagano Perivascular superoxide anion contributes to impairment of endothelium-dependent relaxation: role of gp91(phox) Circulation 106 2002 2497 2502
52. A.H. Chamseddine, and F.J. Miller Jr. Gp91phox contributes to NADPH oxidase activity in aortic fibroblasts but not smooth muscle cells Am. J. Physiol. Heart Circ. Physiol. 285 2003 H2284 2289
53. B.L. Prosser, C.W. Ward, and W.J. Lederer X-ROS signaling: rapid mechano-chemo transduction in heart Science 333 2011 1440 1445
54. S.N. Reilly, R. Jayaram, K. Nahar, C. Antoniades, S. Verheule, K.M. Channon, N.J. Alp, U. Schotten, and B. Casadei Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins Circulation 124 2011 1107 1117
55. M. Wang, J. Zhang, S.J. Walker, R. Dworakowski, E.G. Lakatta, and A.M. Shah Involvement of NADPH oxidase in age-associated cardiac remodeling J. Mol. Cell. Cardiol. 48 2010 765 772
56. F.R. Sheppard, M.R. Kelher, E.E. Moore, N.J. McLaughlin, A. Banerjee, and C.C. Silliman Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation J. Leukoc. Biol. 78 2005 1025 1042
57. A.J. Casbon, L.A. Allen, K.W. Dunn, and M.C. Dinauer Macrophage NADPH oxidase flavocytochrome B localizes to the plasma membrane and Rab11-positive recycling endosomes J. Immunol. 182 2009 2325 2339
58. Y.S. Bae, J.H. Lee, S.H. Choi, S. Kim, F. Almazan, J.L. Witztum, and Y.I. Miller Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2 Circ. Res. 104 2009 210 218
59. S. Chlopicki, R. Olszanecki, M. Janiszewski, F.R. Laurindo, T. Panz, and J. Miedzobrodzki Functional role of NADPH oxidase in activation of platelets Antioxid. Redox Signal. 6 2004 691 698
60. C.F. Lee, M. Qiao, K. Schroder, Q. Zhao, and R. Asmis Nox4 is a novel inducible source of reactive oxygen species in monocytes and macrophages and mediates oxidized low density lipoprotein-induced macrophage death Circ. Res. 106 2010 1489 1497
61. S.H. Bengtsson, L.M. Gulluyan, G.J. Dusting, and G.R. Drummond Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology Clin. Exp. Pharmacol. Physiol. 30 2003 849 854
62. A. Gorlach, R.P. Brandes, K. Nguyen, M. Amidi, F. Dehghani, and R. Busse A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall Circ. Res. 87 2000 26 32
63. J.D. Van Buul, M. Fernandez-Borja, E.C. Anthony, and P.L. Hordijk Expression and localization of NOX2 and NOX4 in primary human endothelial cells Antioxid. Redox Signal. 7 2005 308 317
64. R.E. Clempus, D. Sorescu, A.E. Dikalova, L. Pounkova, P. Jo, G.P. Sorescu, H.H. Schmidt, B. Lassegue, and K.K. Griendling Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype Arterioscler. Thromb. Vasc. Biol. 27 2007 42 48
65. S.H. Ellmark, G.J. Dusting, M.N. Fui, N. Guzzo-Pernell, and G.R. Drummond The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle Cardiovasc. Res. 65 2005 495 504
66. K. Bedard, and K.H. Krause The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology Physiol. Rev. 87 2007 245 313
67. 2 drives DNA oxidation resulting in 8-OHdG as urinary biomarker and hemangioendothelioma formation Antioxid. Redox Signal. 12 2010 933 943
68. S.I. Dikalov, A.E. Dikalova, A.T. Bikineyeva, H.H. Schmidt, D.G. Harrison, and K.K. Griendling Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production Free Radic. Biol. Med. 45 2008 1340 1351
69. M.O. Price, L.C. McPhail, J.D. Lambeth, C.H. Han, U.G. Knaus, and M.C. Dinauer Creation of a genetic system for analysis of the phagocyte respiratory burst: high-level reconstitution of the NADPH oxidase in a nonhematopoietic system Blood 99 2002 2653 2661
70. K.D. Martyn, L.M. Frederick, K. von Loehneysen, M.C. Dinauer, and U.G. Knaus Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases Cell. Signal. 18 2006 69 82
71. S. Basuroy, S. Bhattacharya, C.W. Leffler, and H. Parfenova Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-α in cerebral vascular endothelial cells Am. J. Physiol. Cell Physiol. 296 2009 C422 432
72. D. Meng, D.D. Lv, and J. Fang Insulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cells Cardiovasc. Res. 80 2008 299 308
73. Y. Gorin, J.M. Ricono, N.H. Kim, B. Bhandari, G.G. Choudhury, and H.E. Abboud Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells Am. J. Physiol. Renal Physiol. 285 2003 F219 229
74. J. Zhuang, T. Jiang, D. Lu, Y. Luo, C. Zheng, J. Feng, D. Yang, C. Chen, and X. Yan NADPH oxidase 4 mediates reactive oxygen species induction of CD146 dimerization in VEGF signal transduction Free Radic. Biol. Med. 49 2010 227 236
75. A.N. Lyle, N.N. Deshpande, Y. Taniyama, B. Seidel-Rogol, L. Pounkova, P. Du, C. Papaharalambus, B. Lassegue, and K.K. Griendling Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells Circ. Res. 105 2009 249 259
76. B. Diaz, G. Shani, I. Pass, D. Anderson, M. Quintavalle, and S.A. Courtneidge Tks5-dependent, nox-mediated generation of reactive oxygen species is necessary for invadopodia formation Sci. Signal. 2 2009 ra53
77. S. Ismail, A. Sturrock, P. Wu, B. Cahill, K. Norman, T. Huecksteadt, K. Sanders, T. Kennedy, and J. Hoidal NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-β1 and insulin-like growth factor binding protein-3 Am. J. Physiol. Lung Cell. Mol. Physiol. 296 2009 L489 499
78. D. Sorescu, D. Weiss, B. Lassegue, R.E. Clempus, K. Szocs, G.P. Sorescu, L. Valppu, M.T. Quinn, J.D. Lambeth, J.D. Vega, W.R. Taylor, and K.K. Griendling Superoxide production and expression of nox family proteins in human atherosclerosis Circulation 105 2002 1429 1435
79. A. Yogi, C. Mercure, J. Touyz, G.E. Callera, A.C. Montezano, A.B. Aranha, R.C. Tostes, T. Reudelhuber, and R.M. Touyz Renal redox-sensitive signaling, but not blood pressure, is attenuated by Nox1 knockout in angiotensin II-dependent chronic hypertension Hypertension 51 2008 500 506
80. G. Gavazzi, B. Banfi, C. Deffert, L. Fiette, M. Schappi, F. Herrmann, and K.H. Krause Decreased blood pressure in NOX1-deficient mice FEBS Lett. 580 2006 497 504
81. M.Y. Lee, A. San Martin, P.K. Mehta, A.E. Dikalova, A.M. Garrido, S.R. Datla, E. Lyons, K.H. Krause, B. Banfi, J.D. Lambeth, B. Lassegue, and K.K. Griendling Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation Arterioscler. Thromb. Vasc. Biol. 29 2009 480 487
82. P. Haddad, S. Dussault, J. Groleau, J. Turgeon, S.E. Michaud, C. Menard, G. Perez, F. Maingrette, and A. Rivard Nox2-containing NADPH oxidase deficiency confers protection from hindlimb ischemia in conditions of increased oxidative stress Arterioscler. Thromb. Vasc. Biol. 29 2009 1522 1528
83. P. Haddad, S. Dussault, J. Groleau, J. Turgeon, F. Maingrette, and A. Rivard Nox2-derived reactive oxygen species contribute to hypercholesterolemia- induced inhibition of neovascularization: effects on endothelial progenitor cells and mature endothelial cells Atherosclerosis 217 2011 340 349
84. N. Urao, H. Inomata, M. Razvi, H.W. Kim, K. Wary, R. McKinney, T. Fukai, and M. Ushio-Fukai Role of nox2-based NADPH oxidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia Circ. Res. 103 2008 212 220
85. T. Tojo, M. Ushio-Fukai, M. Yamaoka-Tojo, S. Ikeda, N. Patrushev, and R.W. Alexander Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia Circulation 111 2005 2347 2355
86. M. Maytin, D.A. Siwik, M. Ito, L. Xiao, D.B. Sawyer, R. Liao, and W.S. Colucci Pressure overload-induced myocardial hypertrophy in mice does not require gp91phox Circulation 109 2004 1168 1171
87. E.A. Kirk, M.C. Dinauer, H. Rosen, A. Chait, J.W. Heinecke, and R.C. LeBoeuf Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice Arterioscler. Thromb. Vasc. Biol. 20 2000 1529 1535
88. U. Landmesser, H. Cai, S. Dikalov, L. McCann, J. Hwang, H. Jo, S.M. Holland, and D.G. Harrison Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II Hypertension 40 2002 511 515
89. M. Satoh, H. Ogita, K. Takeshita, Y. Mukai, D.J. Kwiatkowski, and J.K. Liao Requirement of Rac1 in the development of cardiac hypertrophy Proc. Natl. Acad. Sci. U. S. A. 103 2006 7432 7437
90. A. Dikalova, R. Clempus, B. Lassegue, G. Cheng, J. McCoy, S. Dikalov, A. San Martin, A. Lyle, D.S. Weber, D. Weiss, W.R. Taylor, H.H. Schmidt, G.K. Owens, J.D. Lambeth, and K.K. Griendling Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice Circulation 112 2005 2668 2676
91. K. Matsuno, H. Yamada, K. Iwata, D. Jin, M. Katsuyama, M. Matsuki, S. Takai, K. Yamanishi, M. Miyazaki, H. Matsubara, and C. Yabe-Nishimura Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice Circulation 112 2005 2677 2685
92. C.E. Murdoch, S.P. Alom-Ruiz, M. Wang, M. Zhang, S. Walker, B. Yu, A. Brewer, and A.M. Shah Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction Basic Res. Cardiol. 106 2011 527 538
93. R. Ray, C.E. Murdoch, M. Wang, C.X. Santos, M. Zhang, S. Alom-Ruiz, N. Anilkumar, A. Ouattara, A.C. Cave, S.J. Walker, D.J. Grieve, R.L. Charles, P. Eaton, A.C. Brewer, and A.M. Shah Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo Arterioscler. Thromb. Vasc. Biol. 31 2011 1368 1376
94. D.S. Weber, P. Rocic, A.M. Mellis, K. Laude, A.N. Lyle, D.G. Harrison, and K.K. Griendling Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle Am. J. Physiol. Heart Circ. Physiol. 288 2005 H37 42
95. J.J. Khatri, C. Johnson, R. Magid, S.M. Lessner, K.M. Laude, S.I. Dikalov, D.G. Harrison, H.J. Sung, Y. Rong, and Z.S. Galis Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma Circulation 109 2004 520 525
96. A. Virdis, M.F. Neves, F. Amiri, R.M. Touyz, and E.L. Schiffrin Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice J. Hypertens. 22 2004 535 542
97. P.N. Seshiah, D.S. Weber, P. Rocic, L. Valppu, Y. Taniyama, and K.K. Griendling Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators Circ. Res. 91 2002 406 413
98. A.E. Dikalova, M.C. Gongora, D.G. Harrison, J.D. Lambeth, S. Dikalov, and K.K. Griendling Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling Am. J. Physiol. Heart Circ. Physiol. 299 2010 H673 679
99. J. Rivera, C.G. Sobey, A.K. Walduck, and G.R. Drummond Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models Redox Rep. 15 2010 50 63
100. X.L. Niu, N.R. Madamanchi, A.E. Vendrov, I. Tchivilev, M. Rojas, C. Madamanchi, R.P. Brandes, K.H. Krause, J. Humphries, A. Smith, K.G. Burnand, and M.S. Runge Nox activator 1: a potential target for modulation of vascular reactive oxygen species in atherosclerotic arteries Circulation 121 2010 549 559
101. P.L. Hordijk Regulation of NADPH oxidases: the role of Rac proteins Circ. Res. 98 2006 453 462
102. R.P. Brandes, and J. Kreuzer Vascular NADPH oxidases: molecular mechanisms of activation Cardiovasc. Res. 65 2005 16 27
103. B. Yang, and V. Rizzo TNF-α potentiates protein-tyrosine nitration through activation of NADPH oxidase and eNOS localized in membrane rafts and caveolae of bovine aortic endothelial cells Am. J. Physiol. Heart Circ. Physiol. 292 2007 H954 962
104. J. Kuroda, K. Nakagawa, T. Yamasaki, K. Nakamura, R. Takeya, F. Kuribayashi, S. Imajoh-Ohmi, K. Igarashi, Y. Shibata, K. Sueishi, and H. Sumimoto The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells Genes Cells 10 2005 1139 1151
105. B. Lener, R. Koziel, H. Pircher, E. Hutter, R. Greussing, D. Herndler-Brandstetter, M. Hermann, H. Unterluggauer, and P. Jansen-Durr The NADPH oxidase Nox4 restricts the replicative lifespan of human endothelial cells Biochem. J. 423 2009 363 374
106. L.L. Hilenski, R.E. Clempus, M.T. Quinn, J.D. Lambeth, and K.K. Griendling Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 24 2004 677 683
107. B. Stanic, M. Katsuyama, and F.J. Miller Jr. An oxidized extracellular oxidation-reduction state increases Nox1 expression and proliferation in vascular smooth muscle cells via epidermal growth factor receptor activation Arterioscler. Thromb. Vasc. Biol. 30 2010 2234 2241
108. A. Manea, L.I. Tanase, M. Raicu, and M. Simionescu Jak/STAT signaling pathway regulates nox1 and nox4-based NADPH oxidase in human aortic smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 30 2010 105 112
109. C.X. Santos, L.Y. Tanaka, J. Wosniak, and F.R. Laurindo Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase Antioxid. Redox Signal. 11 2009 2409 2427
110. E. Pedruzzi, C. Guichard, V. Ollivier, F. Driss, M. Fay, C. Prunet, J.C. Marie, C. Pouzet, M. Samadi, C. Elbim, Y. O'Dowd, M. Bens, A. Vandewalle, M.A. Gougerot-Pocidalo, G. Lizard, and E. Ogier-Denis NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells Mol. Cell. Biol. 24 2004 10703 10717
111. S.A. Gupte, P.M. Kaminski, S. George, L. Kouznestova, S.C. Olson, R. Mathew, T.H. Hintze, and M.S. Wolin Peroxide generation by p47phox-Src activation of Nox2 has a key role in protein kinase C-induced arterial smooth muscle contraction Am. J. Physiol. Heart Circ. Physiol. 296 2009 H1048 1057
112. L.R. Faust, J. el Benna, B.M. Babior, and S.J. Chanock The phosphorylation targets of p47phox, a subunit of the respiratory burst oxidase: functions of the individual target serines as evaluated by site-directed mutagenesis J. Clin. Invest. 96 1995 1499 1505
113. U.G. Knaus, S. Morris, H.J. Dong, J. Chernoff, and G.M. Bokoch Regulation of human leukocyte p21-activated kinases through G protein-coupled receptors Science 269 1995 221 223
114. D. Diekmann, A. Abo, C. Johnston, A.W. Segal, and A. Hall Interaction of Rac with p67phox and regulation of phagocytic NADPH oxidase activity Science 265 1994 531 533
115. K.K. Griendling, C.A. Minieri, J.D. Ollerenshaw, and R.W. Alexander Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells Circ. Res. 74 1994 1141 1148
116. S. Rajagopalan, S. Kurz, T. Munzel, M. Tarpey, B.A. Freeman, K.K. Griendling, and D.G. Harrison Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone J. Clin. Invest. 97 1996 1916 1923
117. T. Inoguchi, P. Li, F. Umeda, H.Y. Yu, M. Kakimoto, M. Imamura, T. Aoki, T. Etoh, T. Hashimoto, M. Naruse, H. Sano, H. Utsumi, and H. Nawata High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells Diabetes 49 2000 1939 1945
118. M. Zhang, P. Song, J. Xu, and M.H. Zou Activation of NAD(P)H oxidases by thromboxane A2 receptor uncouples endothelial nitric oxide synthase Arterioscler. Thromb. Vasc. Biol. 31 2011 125 132
119. K.A. Gauss, L.K. Nelson-Overton, D.W. Siemsen, Y. Gao, F.R. DeLeo, and M.T. Quinn Role of NF-κB in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor-α J. Leukoc. Biol. 82 2007 729 741
120. A. Manea, S.A. Manea, A.V. Gafencu, and M. Raicu Regulation of NADPH oxidase subunit p22(phox) by NF-κB in human aortic smooth muscle cells Arch. Physiol. Biochem. 113 2007 163 172
121. A. Manea, S.A. Manea, A.V. Gafencu, M. Raicu, and M. Simionescu AP-1-dependent transcriptional regulation of NADPH oxidase in human aortic smooth muscle cells: role of p22phox subunit Arterioscler. Thromb. Vasc. Biol. 28 2008 878 885
122. R. Lage, C. Dieguez, A. Vidal-Puig, and M. Lopez AMPK: a metabolic gauge regulating whole-body energy homeostasis Trends Mol. Med. 14 2008 539 549
123. L. Chen, Z.H. Jiao, L.S. Zheng, Y.Y. Zhang, S.T. Xie, Z.X. Wang, and J.W. Wu Structural insight into the autoinhibition mechanism of AMP-activated protein kinase Nature 459 2009 1146 1149
124. S.A. Hawley, J. Boudeau, J.L. Reid, K.J. Mustard, L. Udd, T.P. Makela, D.R. Alessi, and D.G. Hardie Complexes between the LKB1 tumor suppressor, STRAD α/β and MO25 α/β are upstream kinases in the AMP-activated protein kinase cascade J. Biol. 2 2003 28
125. A. Woods, S.R. Johnstone, K. Dickerson, F.C. Leiper, L.G. Fryer, D. Neumann, U. Schlattner, T. Wallimann, M. Carlson, and D. Carling LKB1 is the upstream kinase in the AMP-activated protein kinase cascade Curr. Biol. 13 2003 2004 2008
126. S.A. Hawley, D.A. Pan, K.J. Mustard, L. Ross, J. Bain, A.M. Edelman, B.G. Frenguelli, and D.G. Hardie Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase Cell Metab. 2 2005 9 19
127. 2+/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells Cell Metab. 2 2005 21 33
128. M. Momcilovic, S.P. Hong, and M. Carlson Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro J. Biol. Chem. 281 2006 25336 25343
129. M. Xie, D. Zhang, J.R. Dyck, Y. Li, H. Zhang, M. Morishima, D.L. Mann, G.E. Taffet, A. Baldini, D.S. Khoury, and M.D. Schneider A pivotal role for endogenous TGF-β-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway Proc. Natl. Acad. Sci. U. S. A. 103 2006 17378 17383
130. S.P. Davies, N.R. Helps, P.T. Cohen, and D.G. Hardie 5′-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase: studies using bacterially expressed human protein phosphatase-2Cα and native bovine protein phosphatase-2AC FEBS Lett. 377 1995 421 425
131. Y. Wu, P. Song, J. Xu, M. Zhang, and M.H. Zou Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase J. Biol. Chem. 282 2007 9777 9788
132. N. Kudo, J.G. Gillespie, L. Kung, L.A. Witters, R. Schulz, A.S. Clanachan, and G.D. Lopaschuk Characterization of 5′AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia Biochim. Biophys. Acta 1301 1996 67 75
133. I. Salt, J.W. Celler, S.A. Hawley, A. Prescott, A. Woods, D. Carling, and D.G. Hardie AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the α2 isoform Biochem. J. 334 1998 177 187
134. S. Horman, D. Vertommen, R. Heath, D. Neumann, V. Mouton, A. Woods, U. Schlattner, T. Wallimann, D. Carling, L. Hue, and M.H. Rider Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase α-subunits in heart via hierarchical phosphorylation of Ser485/491 J. Biol. Chem. 281 2006 5335 5340
135. R.L. Hurley, L.K. Barre, S.D. Wood, K.A. Anderson, B.E. Kemp, A.R. Means, and L.A. Witters Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP J. Biol. Chem. 281 2006 36662 36672
136. N. Djouder, R.D. Tuerk, M. Suter, P. Salvioni, R.F. Thali, R. Scholz, K. Vaahtomeri, Y. Auchli, H. Rechsteiner, R.A. Brunisholz, B. Viollet, T.P. Makela, T. Wallimann, D. Neumann, and W. Krek PKA phosphorylates and inactivates AMPKα to promote efficient lipolysis EMBO J. 29 2010 469 481
137. D.G. Hardie AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy Nat. Rev. Mol. Cell Biol. 8 2007 774 785
138. T. Yamauchi, J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, S. Kita, K. Ueki, K. Eto, Y. Akanuma, P. Froguel, F. Foufelle, P. Ferre, D. Carling, S. Kimura, R. Nagai, B.B. Kahn, and T. Kadowaki Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase Nat. Med. 8 2002 1288 1295
139. Z.B. Andrews, Z.W. Liu, N. Walllingford, D.M. Erion, E. Borok, J.M. Friedman, M.H. Tschop, M. Shanabrough, G. Cline, G.I. Shulman, A. Coppola, X.B. Gao, T.L. Horvath, and S. Diano UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals Nature 454 2008 846 851
140. M.J. Watt, N. Dzamko, W.G. Thomas, S. Rose-John, M. Ernst, D. Carling, B.E. Kemp, M.A. Febbraio, and G.R. Steinberg CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK Nat. Med. 12 2006 541 548
141. G. Zhou, R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, N. Fujii, N. Musi, M.F. Hirshman, L.J. Goodyear, and D.E. Moller Role of AMP-activated protein kinase in mechanism of metformin action J. Clin. Invest. 108 2001 1167 1174
142. G. Ceolotto, A. Gallo, I. Papparella, L. Franco, E. Murphy, E. Iori, E. Pagnin, G.P. Fadini, M. Albiero, A. Semplicini, and A. Avogaro Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism Arterioscler. Thromb. Vasc. Biol. 27 2007 2627 2633
143. L.G. Fryer, A. Parbu-Patel, and D. Carling The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways J. Biol. Chem. 277 2002 25226 25232
144. N.K. LeBrasseur, M. Kelly, T.S. Tsao, S.R. Farmer, A.K. Saha, N.B. Ruderman, and E. Tomas Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues Am. J. Physiol. Endocrinol. Metab. 291 2006 E175 181
145. W.S. Kim, Y.S. Lee, S.H. Cha, H.W. Jeong, S.S. Choe, M.R. Lee, G.T. Oh, H.S. Park, K.U. Lee, M.D. Lane, and J.B. Kim Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity Am. J. Physiol. Endocrinol. Metab. 296 2009 E812 819
146. Y. Han, Q. Wang, P. Song, Y. Zhu, and M.H. Zou Redox regulation of the AMP-activated protein kinase PLoS One 5 2010 e15420
147. J.A. Baur, K.J. Pearson, N.L. Price, H.A. Jamieson, C. Lerin, A. Kalra, V.V. Prabhu, J.S. Allard, G. Lopez-Lluch, K. Lewis, P.J. Pistell, S. Poosala, K.G. Becker, O. Boss, D. Gwinn, M. Wang, S. Ramaswamy, K.W. Fishbein, R.G. Spencer, E.G. Lakatta, D. Le Couteur, R.J. Shaw, P. Navas, P. Puigserver, D.K. Ingram, R. de Cabo, and D.A. Sinclair Resveratrol improves health and survival of mice on a high-calorie diet Nature 444 2006 337 342
148. T. Kim, J. Davis, A.J. Zhang, X. He, and S.T. Mathews Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells Biochem. Biophys. Res. Commun. 388 2009 377 382
149. B. Viollet, S. Horman, J. Leclerc, L. Lantier, M. Foretz, M. Billaud, S. Giri, and F. Andreelli AMPK inhibition in health and disease Crit. Rev. Biochem. Mol. Biol. 45 2010 276 295
150. J. Li, D.L. Coven, E.J. Miller, X. Hu, M.E. Young, D. Carling, A.J. Sinusas, and L.H. Young Activation of AMPK α- and γ-isoform complexes in the intact ischemic rat heart Am. J. Physiol. Heart Circ. Physiol. 291 2006 H1927 1934
151. C. Beauloye, L. Bertrand, S. Horman, and L. Hue AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure Cardiovasc. Res. 90 2011 224 233
152. E. Blair, C. Redwood, H. Ashrafian, M. Oliveira, J. Broxholme, B. Kerr, A. Salmon, I. Ostman-Smith, and H. Watkins Mutations in the γ(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis Hum. Mol. Genet. 10 2001 1215 1220
153. R. Shibata, K. Sato, D.R. Pimentel, Y. Takemura, S. Kihara, K. Ohashi, T. Funahashi, N. Ouchi, and K. Walsh Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms Nat. Med. 11 2005 1096 1103
154. E.J. Miller, J. Li, L. Leng, C. McDonald, T. Atsumi, R. Bucala, and L.H. Young Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart Nature 451 2008 578 582
155. M. Shimano, N. Ouchi, K. Nakamura, B. van Wijk, K. Ohashi, Y. Asaumi, A. Higuchi, D.R. Pimentel, F. Sam, T. Murohara, M.J. van den Hoff, and K. Walsh Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload Proc. Natl. Acad. Sci. U. S. A. 108 2011 E899 906
156. A.Y. Chan, V.W. Dolinsky, C.L. Soltys, B. Viollet, S. Baksh, P.E. Light, and J.R. Dyck Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt J. Biol. Chem. 283 2008 24194 24201
157. S.J. Baron, J. Li, R.R. Russell III, D. Neumann, E.J. Miller, R. Tuerk, T. Wallimann, R.L. Hurley, L.A. Witters, and L.H. Young Dual mechanisms regulating AMPK kinase action in the ischemic heart Circ. Res. 96 2005 337 345
158. Y. Nishino, T. Miura, T. Miki, J. Sakamoto, Y. Nakamura, Y. Ikeda, H. Kobayashi, and K. Shimamoto Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection Cardiovasc. Res. 61 2004 610 619
159. J. Gamble, and G.D. Lopaschuk Insulin inhibition of 5′ adenosine monophosphate-activated protein kinase in the heart results in activation of acetyl coenzyme A carboxylase and inhibition of fatty acid oxidation Metabolism 46 1997 1270 1274
160. C. Beauloye, A.S. Marsin, L. Bertrand, U. Krause, D.G. Hardie, J.L. Vanoverschelde, and L. Hue Insulin antagonizes AMP-activated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides FEBS Lett. 505 2001 348 352
161. N. Kudo, A.J. Barr, R.L. Barr, S. Desai, and G.D. Lopaschuk High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase J. Biol. Chem. 270 1995 17513 17520
162. A.S. Marsin, L. Bertrand, M.H. Rider, J. Deprez, C. Beauloye, M.F. Vincent, G. Van den Berghe, D. Carling, and L. Hue Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia Curr. Biol. 10 2000 1247 1255
163. R.R. Russell III, J. Li, D.L. Coven, M. Pypaert, C. Zechner, M. Palmeri, F.J. Giordano, J. Mu, M.J. Birnbaum, and L.H. Young AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury J. Clin. Invest. 114 2004 495 503
164. L.H. Young AMP-activated protein kinase conducts the ischemic stress response orchestra Circulation 117 2008 832 840
165. H.L. Li, R. Yin, D. Chen, D. Liu, D. Wang, Q. Yang, and Y.G. Dong Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy J. Cell. Biochem. 100 2007 1086 1099
166. R. Tian, N. Musi, J. D'Agostino, M.F. Hirshman, and L.J. Goodyear Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy Circulation 104 2001 1664 1669
167. E. Zarrinpashneh, C. Beauloye, A. Ginion, A.C. Pouleur, X. Havaux, L. Hue, B. Viollet, J.L. Vanoverschelde, and L. Bertrand AMPKα2 counteracts the development of cardiac hypertrophy induced by isoproterenol Biochem. Biophys. Res. Commun. 376 2008 677 681
168. P. Zhang, X. Hu, X. Xu, J. Fassett, G. Zhu, B. Viollet, W. Xu, B. Wiczer, D.A. Bernlohr, R.J. Bache, and Y. Chen AMP activated protein kinase-α2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice Hypertension 52 2008 918 924
169. X. Hu, X. Xu, Z. Lu, P. Zhang, J. Fassett, Y. Zhang, Y. Xin, J.L. Hall, B. Viollet, R.J. Bache, Y. Huang, and Y. Chen AMP activated protein kinase-α2 regulates expression of estrogen-related receptor-α, a metabolic transcription factor related to heart failure development Hypertension 58 2011 696 703
170. Y. Matsui, H. Takagi, X. Qu, M. Abdellatif, H. Sakoda, T. Asano, B. Levine, and J. Sadoshima Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy Circ. Res. 100 2007 914 922
171. Z. Xie, K. Lau, B. Eby, P. Lozano, C. He, B. Pennington, H. Li, S. Rathi, Y. Dong, R. Tian, D. Kem, and M.H. Zou Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice Diabetes 60 2011 1770 1778
172. Y. Dong, M. Zhang, B. Liang, Z. Xie, Z. Zhao, S. Asfa, H.C. Choi, and M.H. Zou Reduction of AMP-activated protein kinase α2 increases endoplasmic reticulum stress and atherosclerosis in vivo Circulation 121 2010 792 803
173. B. Fisslthaler, and I. Fleming Activation and signaling by the AMP-activated protein kinase in endothelial cells Circ. Res. 105 2009 114 127
174. S.L. Colombo, and S. Moncada AMPKα1 regulates the antioxidant status of vascular endothelial cells Biochem. J. 421 2009 163 169
175. D. Nagata, M. Mogi, and K. Walsh AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress J. Biol. Chem. 278 2003 31000 31006
176. K.M. Neurath, M.P. Keough, T. Mikkelsen, and K.P. Claffey AMP-dependent protein kinase α2 isoform promotes hypoxia-induced VEGF expression in human glioblastoma Glia 53 2006 733 743
177. Z. Xie, Y. Dong, M. Zhang, M.Z. Cui, R.A. Cohen, U. Riek, D. Neumann, U. Schlattner, and M.H. Zou Activation of protein kinase Cζ by peroxynitrite regulates LKB1-dependent AMP-activated protein kinase in cultured endothelial cells J. Biol. Chem. 281 2006 6366 6375
178. Z. Xie, Y. Dong, R. Scholz, D. Neumann, and M.H. Zou Phosphorylation of LKB1 at serine 428 by protein kinase C-ζ is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells Circulation 117 2008 952 962
179. Z. Xie, Y. Dong, J. Zhang, R. Scholz, D. Neumann, and M.H. Zou Identification of the serine 307 of LKB1 as a novel phosphorylation site essential for its nucleocytoplasmic transport and endothelial cell angiogenesis Mol. Cell. Biol. 29 2009 3582 3596
180. H.C. Choi, P. Song, Z. Xie, Y. Wu, J. Xu, M. Zhang, Y. Dong, S. Wang, K. Lau, and M.H. Zou Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo J. Biol. Chem. 283 2008 20186 20197
181. Z. Chen, I.C. Peng, W. Sun, M.I. Su, P.H. Hsu, Y. Fu, Y. Zhu, K. DeFea, S. Pan, M.D. Tsai, and J.Y. Shyy AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633 Circ. Res. 104 2009 496 505
182. M. Akaike, W. Che, N.L. Marmarosh, S. Ohta, M. Osawa, B. Ding, B.C. Berk, C. Yan, and J. Abe The hinge-helix 1 region of peroxisome proliferator- activated receptor γ1 (PPARγ1) mediates interaction with extracellular signal-regulated kinase 5 and PPARγ1 transcriptional activation: involvement in flow-induced PPARγ activation in endothelial cells Mol. Cell. Biol. 24 2004 8691 8704
183. S. Wang, J. Xu, P. Song, B. Viollet, and M.H. Zou In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I Diabetes 58 2009 1893 1901
184. W.J. Lee, I.K. Lee, H.S. Kim, Y.M. Kim, E.H. Koh, J.C. Won, S.M. Han, M.S. Kim, I. Jo, G.T. Oh, I.S. Park, J.H. Youn, S.W. Park, K.U. Lee, and J.Y. Park α-Lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase Arterioscler. Thromb. Vasc. Biol. 25 2005 2488 2494
185. M.H. Zou, and Y. Wu AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function Clin. Exp. Pharmacol. Physiol. 35 2008 535 545
186. V.A. Morrow, F. Foufelle, J.M. Connell, J.R. Petrie, G.W. Gould, and I.P. Salt Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells J. Biol. Chem. 278 2003 31629 31639
187. B.J. Davis, Z. Xie, B. Viollet, and M.H. Zou Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase Diabetes 55 2006 496 505
188. Y. Wang, Y. Huang, K.S. Lam, Y. Li, W.T. Wong, H. Ye, C.W. Lau, P.M. Vanhoutte, and A. Xu Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase Cardiovasc. Res. 82 2009 484 492
189. X. Li, Y. Han, W. Pang, C. Li, X. Xie, J.Y. Shyy, and Y. Zhu AMP-activated protein kinase promotes the differentiation of endothelial progenitor cells Arterioscler. Thromb. Vasc. Biol. 28 2008 1789 1795
190. N. Ouchi, R. Shibata, and K. Walsh AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle Circ. Res. 96 2005 838 846
191. M.J. Xu, P. Song, N. Shirwany, B. Liang, J. Xing, B. Viollet, X. Wang, Y. Zhu, and M.H. Zou Impaired expression of uncoupling protein 2 causes defective postischemic angiogenesis in mice deficient in AMP-activated protein kinase α subunits Arterioscler. Thromb. Vasc. Biol. 31 2011 1757 1765
192. C. Liu, B. Liang, Q. Wang, J. Wu, and M.H. Zou Activation of AMP-activated protein kinase α1 alleviates endothelial cell apoptosis by increasing the expression of anti-apoptotic proteins Bcl-2 and survivin J. Biol. Chem. 285 2010 15346 15355
193. F. Goirand, M. Solar, Y. Athea, B. Viollet, P. Mateo, D. Fortin, J. Leclerc, J. Hoerter, R. Ventura-Clapier, and A. Garnier Activation of AMP kinase α1 subunit induces aortic vasorelaxation in mice J. Physiol. 581 2007 1163 1171
194. E. Zarrinpashneh, K. Carjaval, C. Beauloye, A. Ginion, P. Mateo, A.C. Pouleur, S. Horman, S. Vaulont, J. Hoerter, B. Viollet, L. Hue, J.L. Vanoverschelde, and L. Bertrand Role of the α2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia Am. J. Physiol. Heart Circ. Physiol. 291 2006 H2875 2883
195. K. Carvajal, E. Zarrinpashneh, O. Szarszoi, F. Joubert, Y. Athea, P. Mateo, B. Gillet, S. Vaulont, B. Viollet, X. Bigard, L. Bertrand, R. Ventura-Clapier, and J.A. Hoerter Dual cardiac contractile effects of the α2-AMPK deletion in low-flow ischemia and reperfusion Am. J. Physiol. Heart Circ. Physiol. 292 2007 H3136 3147
196. Y. Dong, M. Zhang, S. Wang, B. Liang, Z. Zhao, C. Liu, M. Wu, H.C. Choi, T.J. Lyons, and M.H. Zou Activation of AMP-activated protein kinase inhibits oxidized LDL-triggered endoplasmic reticulum stress in vivo Diabetes 59 2010 1386 1396
197. S. Wang, B. Liang, B. Viollet, and M.H. Zou Inhibition of the AMP-activated protein kinase-α2 accentuates agonist-induced vascular smooth muscle contraction and high blood pressure in mice Hypertension 57 2011 1010 1017
198. P. Song, S. Wang, C. He, B. Liang, B. Viollet, and M.H. Zou AMPKα2 deletion exacerbates neointima formation by upregulating Skp2 in vascular smooth muscle cells Circ. Res. 109 2011 1230 1239
199. S.K. Banerjee, R. Ramani, S. Saba, J. Rager, R. Tian, M.A. Mathier, and F. Ahmad A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia Biochem. Biophys. Res. Commun. 360 2007 381 387
200. M. Arad, I.P. Moskowitz, V.V. Patel, F. Ahmad, A.R. Perez-Atayde, D.B. Sawyer, M. Walter, G.H. Li, P.G. Burgon, C.T. Maguire, D. Stapleton, J.P. Schmitt, X.X. Guo, A. Pizard, S. Kupershmidt, D.M. Roden, C.I. Berul, C.E. Seidman, and J.G. Seidman Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy Circulation 107 2003 2850 2856
201. I. Luptak, M. Shen, H. He, M.F. Hirshman, N. Musi, L.J. Goodyear, J. Yan, H. Wakimoto, H. Morita, M. Arad, C.E. Seidman, J.G. Seidman, J.S. Ingwall, J.A. Balschi, and R. Tian Aberrant activation of AMP-activated protein kinase remodels metabolic network in favor of cardiac glycogen storage J. Clin. Invest. 117 2007 1432 1439
202. J.K. Davies, D.J. Wells, K. Liu, H.R. Whitrow, T.D. Daniel, R. Grignani, C.A. Lygate, J.E. Schneider, G. Noel, H. Watkins, and D. Carling Characterization of the role of γ2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome Am. J. Physiol. Heart Circ. Physiol. 290 2006 H1942 1951
203. J.S. Sidhu, Y.S. Rajawat, T.G. Rami, M.H. Gollob, Z. Wang, R. Yuan, A.J. Marian, F.J. DeMayo, D. Weilbacher, G.E. Taffet, J.K. Davies, D. Carling, D.S. Khoury, and R. Roberts Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome Circulation 111 2005 21 29
204. Y. Xing, N. Musi, N. Fujii, L. Zou, I. Luptak, M.F. Hirshman, L.J. Goodyear, and R. Tian Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative α2 subunit of AMP-activated protein kinase J. Biol. Chem. 278 2003 28372 28377
205. J.W. Calvert, S. Gundewar, S. Jha, J.J. Greer, W.H. Bestermann, R. Tian, and D.J. Lefer Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling Diabetes 57 2008 696 705
206. L.J. Rubin, L. Magliola, X. Feng, A.W. Jones, and C.C. Hale Metabolic activation of AMP kinase in vascular smooth muscle J. Appl. Physiol. 98 2005 296 306
207. M. Zhang, Y. Dong, J. Xu, Z. Xie, Y. Wu, P. Song, M. Guzman, J. Wu, and M.H. Zou Thromboxane receptor activates the AMP-activated protein kinase in vascular smooth muscle cells via hydrogen peroxide Circ. Res. 102 2008 328 337
208. M. Igata, H. Motoshima, K. Tsuruzoe, K. Kojima, T. Matsumura, T. Kondo, T. Taguchi, K. Nakamaru, M. Yano, D. Kukidome, K. Matsumoto, T. Toyonaga, T. Asano, T. Nishikawa, and E. Araki Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression Circ. Res. 97 2005 837 844
209. D. Nagata, R. Takeda, M. Sata, H. Satonaka, E. Suzuki, T. Nagano, and Y. Hirata AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation Circulation 110 2004 444 451
210. S.Y. Kim, N.H. Jeoung, C.J. Oh, Y.K. Choi, H.J. Lee, H.J. Kim, J.Y. Kim, J.H. Hwang, S. Tadi, Y.H. Yim, K.U. Lee, K.G. Park, S. Huh, K.N. Min, K.H. Jeong, M.G. Park, T.H. Kwak, G.R. Kweon, K. Inukai, M. Shong, and I.K. Lee Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation Circ. Res. 104 2009 842 850
211. S. Horman, N. Morel, D. Vertommen, N. Hussain, D. Neumann, C. Beauloye, N. El Najjar, C. Forcet, B. Viollet, M.P. Walsh, L. Hue, and M.H. Rider AMP-activated protein kinase phosphorylates and desensitizes smooth muscle myosin light chain kinase J. Biol. Chem. 283 2008 18505 18512
212. D. Sag, D. Carling, R.D. Stout, and J. Suttles Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype J. Immunol. 181 2008 8633 8641
213. Z. Yang, B.B. Kahn, H. Shi, and B.Z. Xue Macrophage α1 AMP-activated protein kinase (α1AMPK) antagonizes fatty acid-induced inflammation through SIRT1 J. Biol. Chem. 285 2010 19051 19059
214. A.S. Marsin, C. Bouzin, L. Bertrand, and L. Hue The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase J. Biol. Chem. 277 2002 30778 30783
215. H. Moir, M.G. Hughes, S. Potter, C. Sims, L.R. Butcher, N.A. Davies, K. Verheggen, K.P. Jones, A.W. Thomas, and R. Webb Exercise-induced immunosuppression: roles of reactive oxygen species and 5′-AMP-activated protein kinase dephosphorylation within immune cells J. Appl. Physiol. 108 2010 1284 1292
216. H.W. Jeong, K.C. Hsu, J.W. Lee, M. Ham, J.Y. Huh, H.J. Shin, W.S. Kim, and J.B. Kim Berberine suppresses proinflammatory responses through AMPK activation in macrophages Am. J. Physiol. Endocrinol. Metab. 296 2009 E955 964
217. X. Zhao, J.W. Zmijewski, E. Lorne, G. Liu, Y.J. Park, Y. Tsuruta, and E. Abraham Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury Am. J. Physiol. Lung Cell. Mol. Physiol. 295 2008 L497 504
218. H.B. Bae, J.W. Zmijewski, J.S. Deshane, J.M. Tadie, D.D. Chaplin, S. Takashima, and E. Abraham AMP-activated protein kinase enhances the phagocytic ability of macrophages and neutrophils FASEB J. 25 2011 4358 4368
219. S. Wang, G.L. Dale, P. Song, B. Viollet, and M.H. Zou AMPKα1 deletion shortens erythrocyte life span in mice: role of oxidative stress J. Biol. Chem. 285 2010 19976 19985
220. M. Foller, M. Sopjani, S. Koka, S. Gu, H. Mahmud, K. Wang, E. Floride, E. Schleicher, E. Schulz, T. Munzel, and F. Lang Regulation of erythrocyte survival by AMP-activated protein kinase FASEB J. 23 2009 1072 1080
221. M. Foretz, S. Guihard, J. Leclerc, V. Fauveau, J.P. Couty, F. Andris, M. Gaudry, F. Andreelli, S. Vaulont, and B. Viollet Maintenance of red blood cell integrity by AMP-activated protein kinase α1 catalytic subunit FEBS Lett. 584 2010 3667 3671
222. V. Randriamboavonjy, J. Isaak, T. Fromel, B. Viollet, B. Fisslthaler, K.T. Preissner, and I. Fleming AMPK α2 subunit is involved in platelet signaling, clot retraction, and thrombus stability Blood 116 2010 2134 2140
223. I. Fleming, C. Schulz, B. Fichtlscherer, B.E. Kemp, B. Fisslthaler, and R. Busse AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets Thromb. Haemost. 90 2003 863 871
224. T. Toyoda, T. Hayashi, L. Miyamoto, S. Yonemitsu, M. Nakano, S. Tanaka, K. Ebihara, H. Masuzaki, K. Hosoda, G. Inoue, A. Otaka, K. Sato, T. Fushiki, and K. Nakao Possible involvement of the α1 isoform of 5′AMP-activated protein kinase in oxidative stress-stimulated glucose transport in skeletal muscle Am. J. Physiol. Endocrinol. Metab. 287 2004 E166 173
225. M.H. Zou, X.Y. Hou, C.M. Shi, D. Nagata, K. Walsh, and R.A. Cohen Modulation by peroxynitrite of Akt- and AMP-activated kinase-dependent Ser1179 phosphorylation of endothelial nitric oxide synthase J. Biol. Chem. 277 2002 32552 32557
226. M.H. Zou, S.S. Kirkpatrick, B.J. Davis, J.S. Nelson, W.G.t. Wiles, U. Schlattner, D. Neumann, M. Brownlee, M.B. Freeman, and M.H. Goldman Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo: role of mitochondrial reactive nitrogen species J. Biol. Chem. 279 2004 43940 43951
227. M.H. Zou, X.Y. Hou, C.M. Shi, S. Kirkpatick, F. Liu, M.H. Goldman, and R.A. Cohen Activation of 5′-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells: role of peroxynitrite J. Biol. Chem. 278 2003 34003 34010
228. G.A. Gusarova, L.A. Dada, A.M. Kelly, C. Brodie, L.A. Witters, N.S. Chandel, and J.I. Sznajder α1-AMP-activated protein kinase regulates hypoxia-induced Na,K-ATPase endocytosis via direct phosphorylation of protein kinase Cζ Mol. Cell. Biol. 29 2009 3455 3464
229. B.M. Emerling, F. Weinberg, C. Snyder, Z. Burgess, G.M. Mutlu, B. Viollet, G.R. Budinger, and N.S. Chandel Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio Free Radic. Biol. Med. 46 2009 1386 1391
230. P.T. Mungai, G.B. Waypa, A. Jairaman, M. Prakriya, D. Dokic, M.K. Ball, and P.T. Schumacker Hypoxia triggers AMPK activation through reactive oxygen species-mediated activation of calcium release-activated calcium channels Mol. Cell. Biol. 31 2011 3531 3545
231. 2 Biochem. Biophys. Res. Commun. 287 2001 92 97
232. J.W. Zmijewski, S. Banerjee, H. Bae, A. Friggeri, E.R. Lazarowski, and E. Abraham Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase J. Biol. Chem. 285 2010 33154 33164
233. P. Song, Y. Wu, J. Xu, Z. Xie, Y. Dong, M. Zhang, and M.H. Zou Reactive nitrogen species induced by hyperglycemia suppresses Akt signaling and triggers apoptosis by upregulating phosphatase PTEN (phosphatase and tensin homologue deleted on chromosome 10) in an LKB1-dependent manner Circulation 116 2007 1585 1595
234. N.A. Shirwany, and M.H. Zou AMPK in cardiovascular health and disease Acta Pharmacol. Sin. 31 2010 1075 1084
235. N.B. Ruderman, J.M. Cacicedo, S. Itani, N. Yagihashi, A.K. Saha, J.M. Ye, K. Chen, M. Zou, D. Carling, G. Boden, R.A. Cohen, J. Keaney, E.W. Kraegen, and Y. Ido Malonyl-CoA and AMP-activated protein kinase (AMPK): possible links between insulin resistance in muscle and early endothelial cell damage in diabetes Biochem. Soc. Trans. 31 2003 202 206
236. D. Kukidome, T. Nishikawa, K. Sonoda, K. Imoto, K. Fujisawa, M. Yano, H. Motoshima, T. Taguchi, T. Matsumura, and E. Araki Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells Diabetes 55 2006 120 127
237. E. Schulz, J. Dopheide, S. Schuhmacher, S.R. Thomas, K. Chen, A. Daiber, P. Wenzel, T. Munzel, and J.F. Keaney Jr. Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction Circulation 118 2008 1347 1357
238. Z. Xie, J. Zhang, J. Wu, B. Viollet, and M.H. Zou Upregulation of mitochondrial uncoupling protein-2 by the AMP-activated protein kinase in endothelial cells attenuates oxidative stress in diabetes Diabetes 57 2008 3222 3230
239. M.F. McCarty, J. Barroso-Aranda, and F. Contreras AMP-activated kinase may suppress NADPH oxidase activation in vascular tissues Med. Hypotheses 72 2009 468 470
240. Y. Hattori, K. Suzuki, S. Hattori, and K. Kasai Metformin inhibits cytokine-induced nuclear factor κB activation via AMP-activated protein kinase activation in vascular endothelial cells Hypertension 47 2006 1183 1188
241. E. Bess, B. Fisslthaler, T. Fromel, and I. Fleming Nitric oxide-induced activation of the AMP-activated protein kinase α2 subunit attenuates IκB kinase activity and inflammatory responses in endothelial cells PLoS One 6 2011 e20848
242. A.A. Eid, B.M. Ford, K. Block, B.S. Kasinath, Y. Gorin, G. Ghosh-Choudhury, J.L. Barnes, and H.E. Abboud AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes J. Biol. Chem. 285 2010 37503 37512
243. M.A. Ewart, and S. Kennedy AMPK and vasculoprotection Pharmacol. Ther. 131 2011 242 253
244. B. Viollet, Y. Athea, R. Mounier, B. Guigas, E. Zarrinpashneh, S. Horman, L. Lantier, S. Hebrard, J. Devin-Leclerc, C. Beauloye, M. Foretz, F. Andreelli, R. Ventura-Clapier, and L. Bertrand AMPK: lessons from transgenic and knockout animals Front. Biosci. 14 2009 19 44
245. D. Nagata, and Y. Hirata The role of AMP-activated protein kinase in the cardiovascular system Hypertens. Res. 33 2010 22 28
246. Q. Xu, and L.Y. Si Protective effects of AMP-activated protein kinase in the cardiovascular system J. Cell. Mol. Med. 14 2010 2604 2613
247. W. Sun, T.S. Lee, M. Zhu, C. Gu, Y. Wang, Y. Zhu, and J.Y. Shyy Statins activate AMP-activated protein kinase in vitro and in vivo Circulation 114 2006 2655 2662
248. L. Tang, Y. Zhang, Y. Jiang, L. Willard, E. Ortiz, L. Wark, D. Medeiros, and D. Lin Dietary wolfberry ameliorates retinal structure abnormalities in db/db mice at the early stage of diabetes Exp. Biol. Med. (Maywood) 236 2011 1051 1063
249. Z.P. Chen, K.I. Mitchelhill, B.J. Michell, D. Stapleton, I. Rodriguez-Crespo, L.A. Witters, D.A. Power, P.R. Ortiz de Montellano, and B.E. Kemp AMP-activated protein kinase phosphorylation of endothelial NO synthase FEBS Lett. 443 1999 285 289
250. E.S. Buhl, N. Jessen, R. Pold, T. Ledet, A. Flyvbjerg, S.B. Pedersen, O. Pedersen, O. Schmitz, and S. Lund Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome Diabetes 51 2002 2199 2206
251. D. Stapleton, K.I. Mitchelhill, G. Gao, J. Widmer, B.J. Michell, T. Teh, C.M. House, C.S. Fernandez, T. Cox, L.A. Witters, and B.E. Kemp Mammalian AMP-activated protein kinase subfamily J. Biol. Chem. 271 1996 611 614